SVN-438

A composition for the prevention or treatment of angiogenesis- and cell proliferation-related disease processes

AUTHOR: Garrido, JM; Sánchez-Montesinos, I.

REGISTRY NO.: P200930321. PCT/ES2010/070403

PRIORITY DATE: 16/06/2009

HOLDER: University of Granada / Andalusian Public Health System

SUMMARY: SUMMARY: A composition comprising a statin and a vascular endothelial activating agent. This composition can be used to prepare medicinal products or pharmaceutical compositions preferably for the prevention or treatment of disease processes associated with abnormal cell proliferation and pathological or undesired angiogenesis such as cancer or arteriosclerosis.

Form

Offer Request

  • Full name.

  • Introduzca su correo electrónico

  • Write a contact phone number.

  • Write your comments here.

  • aviso legal